An Observational Study Investigating the Change in Blood Cholesterol With Mevalotin® Tablet Administration in Korean Menopausal Women Aged 50 Years or More Who Require Treatment of Dyslipidemia

CompletedOBSERVATIONAL
Enrollment

3,060

Participants

Timeline

Start Date

August 10, 2021

Primary Completion Date

September 2, 2024

Study Completion Date

December 27, 2024

Conditions
Dyslipidemia
Interventions
DRUG

Mevalotin

Oral tablets (starting dose 5 mg)

Trial Locations (58)

10380

Inje University Ilsan Paik Hospital, Goyang-si

10475

Myongji Hospital, Goyang-si

11759

Uijeongbu Eulji Medical Center, Eulji University - Site 0053, Uijeongbu-si

Uijeongbu Eulji Medical Center, Eulji University, Uijeongbu-si

11765

The Catholic University of Korea, Uijeongbu St. Mary's Hospital, Uijeongbu-si

11923

Hanyang University Guri Hospital - Site 0022, Guri-si

Hanyang University Guri Hospital - Site 0044, Guri-si

Hanyang University Guri Hospital - Site 0049, Guri-si

13590

Bundang Jesaeng Hospital, Seongnam-si

13620

Seoul National University Bundang Hospital - Site 0001, Seongnam-si

Seoul National University Bundang Hospital - Site 0019, Seongnam-si

14584

Soon Chun Hyang University Hospital Bucheon, Bucheon-si

14754

Bucheon Sejong Hospital, Bucheon-si

16247

The Catholic University of Korea, St. Vincent's Hospital, Suwon

16500

Ajou University Hospital, Suwon

16995

Yonsei University Yongin Severance Hospital, Yŏngin

21431

The Catholic University of Korea, Incheon St. Mary's Hospital, Incheon

21565

Gachon University Gil Medical Center, Incheon

22332

Inha University Hospital, Incheon

24253

Hallym University Medical Center - Chuncheon, Chuncheon

24289

Kangwon National University Hospital - Site 0050, Chuncheon

Kangwon National University Hospital, Chuncheon

26426

Yonsei University, Wonju Severance Christian Hospital - Site 0051, Wŏnju

Yonsei University, Wonju Severance Christian Hospital, Wŏnju

28644

Chungbuk National University Hospital, Cheongju-si

35233

Eulji University Hospital - Site 0004, Daejeon

Eulji University Hospital - Site 0040, Daejeon

35365

Konyang University Hospital, Daejeon

37661

Pohang St. Mary's Hospital, Pohang

37816

SM Christianity Hospital, Pohang

41931

Keimyung University Dongsan Hospital, Daegu

44033

Ulsan Univeristy Hospital, Ulsan

47392

Inje University Busan Paik Hospital, Busan

48108

Inje University Haeundae Paik Hospital - Site 0011, Busan

Inje University Haeundae Paik Hospital - Site 0031, Busan

48775

Boneseng Memorial Hospital, Busan

49241

Pusan National University Hospital - Site 0013, Busan

Pusan National University Hospital - Site 0033, Busan

50612

Pusan National University Yangsan Hospital, Yangsan

52727

Gyeongsang National University Hospital, Jinju

58128

Chonnam National University Hospital Hwasun Hospital, Gwangju

61453

Chosun University Hospital, Gwangju

02841

Korea University Anam Hospital, Seoul

03080

Seoul National University Hospital, Seoul

03181

Kangbuk Samsung Medical Center, Seoul

03312

The Catholic University of Korea, Eunpyeong St. Mary's Hospital, Seoul

03722

Yonsei University Health System, Severance Hospital, Seoul

04401

Soon Chun Hyang University Hospital Seoul, Seoul

04763

Hanyang University Seoul Hospital, Seoul

05278

Kyung Hee University Hospital at Gangdong, Seoul

05368

VHS Medical Center - Site 0020, Seoul

VHS Medical Center - Site 0039, Seoul

06591

The Catholic University of Korea, Seoul St. Mary's Hospital - Site 0018, Seoul

The Catholic University of Korea, Seoul St. Mary's Hospital - Site 0024, Seoul

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul

06973

Chung-Ang University Gwangmyeong Hospital, Seoul

07345

The Catholic University of Korea, Yeouido St. Mary's Hospital, Seoul

07441

Hallym University Medical Center-Kangnam, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Daiichi Sankyo Korea Co., Ltd.

INDUSTRY

lead

Daiichi Sankyo

INDUSTRY

NCT05120895 - An Observational Study Investigating the Change in Blood Cholesterol With Mevalotin® Tablet Administration in Korean Menopausal Women Aged 50 Years or More Who Require Treatment of Dyslipidemia | Biotech Hunter | Biotech Hunter